NCT05142696 2026-03-17A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabNovartisPhase 1/2 Active not recruiting24 enrolled
NCT06897579 2025-04-11Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung CancerChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Recruiting134 enrolled